Clinical Trial Update: The Efficacy of Chemotherapy Combined With Immunocheckpoint Inhibitors in Advanced Biliary Malignancies [Phase 2, Phase 3]

View source ↗

Summary

A trial update evaluating chemotherapy combined with immune checkpoint inhibitors in advanced biliary tract cancers across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Immune checkpoint inhibitors (immune checkpoint inhibitor)

Snippet

Sponsor: First People's Hospital of Hangzhou | Conditions: Gemcitabine, Biliary Tract Cancer | Phase 2, Phase 3 | Status: UNKNOWN